PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $259,597 | +9.0% | 6,383 | +29.8% | 0.00% | 0.0% |
| Q1 2023 | $238,131 | -5.5% | 4,916 | -7.8% | 0.00% | 0.0% |
| Q1 2021 | $252,000 | -34.7% | 5,332 | -15.7% | 0.00% | -50.0% |
| Q4 2020 | $386,000 | -48.2% | 6,327 | -60.3% | 0.00% | -33.3% |
| Q3 2020 | $745,000 | -25.1% | 15,935 | -18.7% | 0.00% | -40.0% |
| Q2 2020 | $995,000 | +19.0% | 19,602 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $836,000 | +195.4% | 18,730 | +217.6% | 0.01% | +400.0% |
| Q4 2019 | $283,000 | +10.1% | 5,897 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $257,000 | -15.2% | 5,703 | -35.4% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -32.1% | 8,823 | -7.1% | 0.00% | 0.0% |
| Q3 2018 | $446,000 | +94.8% | 9,493 | -17.2% | 0.00% | +100.0% |
| Q3 2017 | $229,000 | – | 11,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |